Ece Canan Sayitoglu

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML
  Ece Canan Sayitoğlu, Bogdan A. Luca, Allison P. Boss +12 more
  Leukemia 2024 DOI: 10.1038/s41375-024-02255-1
  +Save
• Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy
  Cytotherapy 2021 DOI: 10.1016/j.jcyt.2021.05.010
  +Save
• The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application
  Frontiers in Immunology 2021 DOI: 10.3389/fimmu.2021.693105
  +Save
• Engineered Type 1 Regulatory T Cells Have a Cytotoxic Profile and Kill Pediatric Acute Myeloid Leukemia Cells
  2021
  +Save
• Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells.
  Brandon Cieniewicz, Molly Javier Uyeda, Pauline P. Chen +10 more
  Haematologica 2020 DOI: 10.3324/haematol.2020.263129
  +Save
• Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells.
  PloS one 2020 DOI: 10.1371/journal.pone.0239238
  +Save
• Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
  Frontiers in immunology 2020 DOI: 10.3389/fimmu.2020.00040
  +Save
• Engineering antigen-specific NK cell lines against the melanoma-associated antigen tyrosinase via TCR gene transfer.
  European journal of immunology 2019 DOI: 10.1002/eji.201948140
  +Save
• Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.
  Proceedings of the National Academy of Sciences of the United States of America 2019 DOI: 10.1073/pnas.1807656116
  +Save
• Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells.
  Cancers 2019 DOI: 10.3390/cancers11010069
  +Save